However, the precise molecular mechanisms by which Cu dyshomeostasis triggers neuronal cuproptosis, the shared and disease-specific features of cuproptosis regulatory pathways across neurodegenerative diseases such as AD and PD, and the dynamic regulation of Cu chaperones including ATP7A/B and CTR1 during disease progression remain largely unclear. This evidence concerns the gene SLC31A1 and Parkinson disease.